86 results on '"van Helden, Paul"'
Search Results
2. Whole genome sequencing improves the discrimination between Mycobacterium bovis strains on the southern border of Kruger National Park, South Africa
3. Complex evolutionary history of felid anelloviruses
4. Diagnostic accuracy of the FluoroType MTB and MTBDR VER 2.0 assays for the centralized high-throughput detection of Mycobacterium tuberculosis complex DNA and isoniazid and rifampicin resistance
5. Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis
6. Development of a cytokine gene expression assay for the relative quantification of the African elephant (Loxodonta africana) cell-mediated immune responses
7. Optimisation of the tuberculin skin test for detection of Mycobacterium bovis in African buffaloes (Syncerus caffer)
8. Cytokine biomarker discovery in the white rhinoceros (Ceratotherium simum)
9. Use of the MILLIPLEX® bovine cytokine/chemokine multiplex assay to identify Mycobacterium bovis-infection biomarkers in African buffaloes (Syncerus caffer)
10. Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study
11. Whole genome sequencing provides additional insights into recurrent tuberculosis classified as endogenous reactivation by IS6110 DNA fingerprinting
12. An interferon-gamma release assay for the diagnosis of the Mycobacterium bovis infection in white rhinoceros (Ceratotherium simum)
13. Impact of Mycobacterium bovis-induced pathology on interpretation of QuantiFERON®-TB Gold assay results in African buffaloes (Syncerus caffer)
14. Evolution of rifampicin treatment for tuberculosis
15. Distinct serum biosignatures are associated with different tuberculosis treatment outcomes
16. Parallel measurement of IFN-γ and IP-10 in QuantiFERON®-TB Gold (QFT) plasma improves the detection of Mycobacterium bovis infection in African buffaloes (Syncerus caffer)
17. The arms race between man and Mycobacterium tuberculosis: Time to regroup
18. Parallel testing increases detection of Mycobacterium bovis-infected African buffaloes (Syncerus caffer)
19. IP-10: A potential biomarker for detection of Mycobacterium bovis infection in warthogs (Phacochoerus africanus)
20. Corrigendum to “Detection of Mycobacterium bovis infection in African buffaloes (Syncerus caffer) using QuantiFERON®-TB Gold (QFT) tubes and the Qiagen cattletype® IFN-gamma ELISA” [J. Vet. Immunol. Immunopathol. 196 (2018) 48–52]
21. Detection of Mycobacterium bovis infection in African buffaloes ( Syncerus caffer ) using QuantiFERON ® -TB Gold (QFT) tubes and the Qiagen cattletype ® IFN-gamma ELISA
22. Mycobacterial nucleoid associated proteins: An added dimension in gene regulation
23. Structural and functional effects of nucleotide variation on the human TB drug metabolizing enzyme arylamine N -acetyltransferase 1
24. Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13
25. Progenitor strain introduction of Mycobacterium bovis at the wildlife-livestock interface can lead to clonal expansion of the disease in a single ecosystem
26. Toll-like receptor (TLR) diversity influences mycobacterial growth in African buffalo
27. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
28. Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable tuberculosis: a prospective cohort study
29. Test performance of three serological assays for the detection of Mycobacterium bovis infection in common warthogs (Phacochoerus africanus)
30. Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosis
31. The stability of plasma IP-10 enhances its utility for the diagnosis of Mycobacterium bovis infection in African buffaloes (Syncerus caffer)
32. Whole genome sequence analysis of Mycobacterium suricattae
33. Association of toll-like receptors with susceptibility to tuberculosis suggests sex-specific effects of TLR8 polymorphisms
34. Mycobacterium bovis infection in the lion (Panthera leo): Current knowledge, conundrums and research challenges
35. Genetic diversity of Mycobacterium tuberculosis isolated from tuberculosis patients in the Serengeti ecosystem in Tanzania
36. Serologic diagnosis of tuberculosis by combining Ig classes against selected mycobacterial targets
37. The evaluation of candidate biomarkers of cell-mediated immunity for the diagnosis of Mycobacterium bovis infection in African buffaloes (Syncerus caffer)
38. The role of ancestry in TB susceptibility of an admixed South African population
39. Agreement between assays of cell-mediated immunity utilizing Mycobacterium bovis-specific antigens for the diagnosis of tuberculosis in African buffaloes (Syncerus caffer)
40. Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study
41. Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study
42. A new TB vaccine: Fact or fiction?
43. Serodiagnostic markers for the prediction of the outcome of intensive phase tuberculosis therapy
44. Development of a diagnostic gene expression assay for tuberculosis and its use under field conditions in African buffaloes (Syncerus caffer)
45. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa
46. European 1: A globally important clonal complex of Mycobacterium bovis
47. Modification of the QuantiFERON-TB Gold (In-Tube) assay for the diagnosis of Mycobacterium bovis infection in African buffaloes (Syncerus caffer)
48. Novel thiolactone–isatin hybrids as potential antimalarial and antitubercular agents
49. Mixed infections of Corynebacterium pseudotuberculosis and non-tuberculous mycobacteria in South African antelopes presenting with tuberculosis-like lesions
50. Using a Label-free Proteomics Method to Identify Differentially Abundant Proteins in Closely Related Hypo- and Hypervirulent Clinical Mycobacterium tuberculosis Beijing Isolates
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.